ArcticZymes Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

ArcticZymes Technologies şirketinin toplam hissedar öz sermayesi NOK318.8M ve toplam borcu NOK0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla NOK341.8M ve NOK22.9M dir.

Anahtar bilgiler

Borç/özkaynak oranı

NOK 0

Borç

Faiz karşılama oranı	n/a
Nakit	NOK 242.12m
Eşitlik	NOK 318.82m
Toplam yükümlülükler	NOK 22.93m
Toplam varlıklar	NOK 341.75m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: B4V 'nin kısa vadeli varlıkları ( NOK280.5M ) kısa vadeli yükümlülüklerini ( NOK17.7M ) aşıyor.

Uzun Vadeli Yükümlülükler: B4V şirketinin kısa vadeli varlıkları ( NOK280.5M ) uzun vadeli yükümlülüklerini ( NOK5.2M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: B4V borçsuzdur.

Borcun Azaltılması: B4V son 5 yıldır borcu bulunmamaktadır.

Borç Kapsamı: B4V un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: B4V şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

ArcticZymes Technologies Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter 2024 earnings released: kr0.03 loss per share (vs kr0.12 profit in 3Q 2023)

Investor sentiment deteriorates as stock falls 18%

Investor sentiment deteriorates as stock falls 16%

New minor risk - Market cap size

New major risk - Earnings quality

Second quarter 2024 earnings released: EPS: kr0.05 (vs kr0.11 in 2Q 2023)

ArcticZymes Technologies ASA Announces the Appointment of Frank Mathias as Chairman of the Board of Directors

Investor sentiment improves as stock rises 19%

New major risk - Earnings quality

Less than half of directors are independent

ArcticZymes Technologies ASA Announces Board Resignations

First quarter 2024 earnings released

ArcticZymes Technologies ASA Announces Resignation of Edgar Koster as Board Member

Investor sentiment deteriorates as stock falls 33%

New major risk - Earnings quality

Full year 2023 earnings released: EPS: kr0.37 (vs kr0.65 in FY 2022)

Arcticzymes Technologies Asa Announces the Launch of Its First Gmp-Grade Product, San Hq

ArcticZymes Technologies ASA Launches T7 RNA Polymerase

ArcticZymes Technologies ASA, Annual General Meeting, Jun 05, 2024

Third quarter 2023 earnings released: EPS: kr0.12 (vs kr0.05 in 3Q 2022)

New minor risk - Share price stability

ArcticZymes Technologies ASA Announces DMF for SAN HQ GMP accepted by the US FDA

Second quarter 2023 earnings released: EPS: kr0.11 (vs kr0.17 in 2Q 2022)

ArcticZymes Technologies ASA Appoints Michael Akoh as Chief Executive Officer, Will Commence His Position No Later Than 1 November 2023

First quarter 2023 earnings released: EPS: kr0.10 (vs kr0.41 in 1Q 2022)

Full year 2022 earnings released: EPS: kr0.65 (vs kr0.94 in FY 2021)

Investor sentiment deteriorated over the past week

ArcticZymes Technologies Launches SAN HQ 2.0 ELISA kit

ArcticZymes Technologies ASA Appoints Darren Ellis as Chief Scientific Officer

ArcticZymes Technologies ASA to Report Q4, 2022 Results on Feb 02, 2023

No independent directors

Third quarter 2022 earnings released: EPS: kr0.05 (vs kr0.14 in 3Q 2021)

ArcticZymes Technologies ASA Announces Resignation of Volker Wedershoven as Board Member

Second quarter 2022 earnings released: EPS: kr0.17 (vs kr0.09 in 2Q 2021)

First quarter 2022 earnings released: EPS: kr0.41 (vs kr0.40 in 1Q 2021)

No independent directors

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

ArcticZymes Technologies ASA Provides Sales Guidance for the Year 2022

ArcticZymes Technologies Launches New Products

Chief Executive Officer recently sold €1.0m worth of stock

Third quarter 2021 earnings released: EPS kr0.14 (vs kr0.19 in 3Q 2020)

Second quarter 2021 earnings released: EPS kr0.09 (vs kr0.44 in 2Q 2020)

Investor sentiment deteriorated over the past week

ArcticZymes Technologies ASA Launches SAN HQ 2.0

Director recently sold €170k worth of stock

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS kr0.40 (vs kr0.28 in 1Q 2020)

New 90-day high: €8.10

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS kr1.75 (vs kr0.13 loss in FY 2019)

ArcticZymes Technologies ASA to Report Q4, 2020 Results on Jan 28, 2021

New 90-day high: €7.74

Investor sentiment improved over the past week

Market bids up stock over the past week

Market bids up stock over the past week

Market pulls back on stock over the past week

New 90-day high: €6.60

ArcticZymes Technologies ASA to Report Q3, 2020 Results on Oct 22, 2020

New 90-day high - €5.40

ArcticZymes Technologies ASA to Report Q2, 2020 Results on Aug 19, 2020

New 90-day high - €4.67

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin